Kathleen E. McGinness

OverviewAI-generated summary

Kathleen E. McGinness, affiliated with the University of Arkansas for Medical Sciences, has a research focus that includes the development of CAR T-cell therapies and mitigating radiation toxicity. Her work on BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, has demonstrated enhanced T cell metabolism and improved anti-tumor activity in preclinical models. Additionally, her research has explored geranylgeranyl transferase inhibitors as a means to mitigate intestinal radiation toxicity.

McGinness's scholarship metrics include an h-index of 14, with 31 total publications and over 1,000 citations. She has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Rupak Pathak, Enoch K. Larrey, H. Terence Cook, and Edith Nathalie Pineda, with whom she shares one publication each. Her most recent publication was in 2025, indicating recent activity in her research endeavors.

Metrics

• h-index: 14
• Publications: 31
• Citations: 1,014